NCT00761657View on ClinicalTrials.gov

Phase 2 Study of Roxadustat in Participants With Anemia and Chronic Kidney Disease Not Requiring Dialysis

PHASE2CompletedINTERVENTIONAL

Enrollment

117

Participants

Timeline

Start Date

November 1, 2006

Primary Completion Date

June 21, 2010

Study Completion Date

June 21, 2010

Conditions

Chronic Kidney DiseaseAnemia

Interventions

DRUG

Roxadustat

Capsule

DRUG

Placebo

Capsule

Trial Locations (34)

11355

Flushing

19096

Wynnewood

27103

Winston-Salem

29118

Orangeburg

29203

Columbia

30901

Augusta

32401

Panama City

33028

Pembroke Pines

33614

Tampa

34471

Ocala

37404

Chattanooga

40202

Louisville

43606

Toledo

44109

Cleveland

48236

Detroit

60616

Chicago

60805

Evergreen Park

67214

Wichita

68510

Lincoln

70809

Baton Rouge

71101

Shreveport

77036

Houston

80002

Arvada

80031

Westminster

85284

Tempe

85381

Peoria

89106

Las Vegas

90095

Los Angeles

90603

Whittier

92123

San Diego

92691

Mission Viejo

95825

Sacramento

97504

Medford

06762

Middlebury

Sponsors

Lead Sponsor

Collaborators (1)

Astellas Pharma Inc

All Listed Sponsors

collaborator

Astellas Pharma Inc

INDUSTRY

lead

FibroGen

INDUSTRY

NCT00761657 - Phase 2 Study of Roxadustat in Participants With Anemia and Chronic Kidney Disease Not Requiring Dialysis | Biotech Hunter | Biotech Hunter